Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.
To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azelaic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Parodi A et al. | Treatment of rosacea. | 2011 | Ann Dermatol Venereol | pmid:22183101 |
May D et al. | Clinical inquiries. What is the most effective treatment for acne rosacea? | 2011 | J Fam Pract | pmid:21301648 |
Pazoki-Toroudi H et al. | Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. | 2011 | Cutan Ocul Toxicol | pmid:21612319 |
Schnopp C and Mempel M | Acne vulgaris in children and adolescents. | 2011 | Minerva Pediatr. | pmid:21909065 |
Del Rosso JQ and Bhatia N | Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. | 2011 | Cutis | pmid:21916272 |
Sheth VM and Pandya AG | Melasma: a comprehensive update: part II. | 2011 | J. Am. Acad. Dermatol. | pmid:21920242 |
Wang H et al. | [Chemical constituents of Halenia elliptica]. | 2011 | Zhongguo Zhong Yao Za Zhi | pmid:22779176 |
Vinaixa M et al. | Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy. | 2011 | PLoS ONE | pmid:22194988 |
Chudasama A et al. | Investigation of microemulsion system for transdermal delivery of itraconazole. | 2011 | J Adv Pharm Technol Res | pmid:22171289 |
Schauber J | [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop]. | 2011 | Hautarzt | pmid:22002717 |